Dear All,
Welcome to the eighth bulletin from the HSE National Immunisation Office which highlights changes in clinical guidance for the COVID-19 vaccination programme.
In this edition we cover
- COVID-19 Vaccine AstraZeneca® dosing interval
- Lancet publication on efficacy of COVID-19 Vaccine AstraZeneca®
- Effectiveness of Comirnaty® Pfizer/BioNtech COVID-19 Vaccine in Israel published in the New England Journal of Medicine
- Pre-print Lancet paper on the impact of 1st dose of Comirnaty® Pfizer/BioNTech COVID-19 Vaccine and COVID-19 Vaccine AstraZeneca® on preventing hospital admissions
- Public Health England (PHE) monitoring of the early impact of COVID-19 of Vaccination in England
- HPRA Safety Update: COVID-19 Vaccines — Overview of National Reporting Experience — 18 February 2021
- HSE COVID-19 Vaccine Development Video
- The Department of Health has published an updated list of the provisional order in which people in Ireland will be vaccinated
- Contact details for queries regarding the COVID-19 vaccination programme:
We also recommend you visit our website as new documents have been added and updates have been made to the existing clinical documents.
A reminder the COVID-19 Vaccine Webinar Series is available from www.hseland.ie. Thank you to the 8,629 people who have completed the series (as of Tuesday 23rd February).
Please share this update with your colleagues to ensure everyone has access to the most up to date information.
Finally a reminder bulletins will be published every week or more frequently, if required.